PVT1 and nonpapillary renal cell carcinoma: The overexpression of PVT1 was found to be not significantly correlated with poor DFS /PFS in patients with ccRCC, with a pooled HR of 1.54 (95% CI = 0.93–2.14; Fig. 5).